Chapman PB - Search Results

1

High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696.

Kirkwood JM, Ibrahim J, Lawson DH, Atkins MB, Agarwala SS, Collins K, Mascari R, Morrissey DM, Chapman PB. Kirkwood JM, et al. Among authors: chapman pb. J Clin Oncol. 2001 Mar 1;19(5):1430-6. doi: 10.1200/JCO.2001.19.5.1430. J Clin Oncol. 2001. PMID: 11230488 Clinical Trial.

2

Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanoma.

Soiffer RJ, Chapman PB, Murray C, Williams L, Unger P, Collins H, Houghton AN, Ritz J. Soiffer RJ, et al. Among authors: chapman pb. Clin Cancer Res. 1997 Jan;3(1):17-24. Clin Cancer Res. 1997. PMID: 9815532 Clinical Trial.

3

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.

Chapman PB, Einhorn LH, Meyers ML, Saxman S, Destro AN, Panageas KS, Begg CB, Agarwala SS, Schuchter LM, Ernstoff MS, Houghton AN, Kirkwood JM. Chapman PB, et al. J Clin Oncol. 1999 Sep;17(9):2745-51. doi: 10.1200/JCO.1999.17.9.2745. J Clin Oncol. 1999. PMID: 10561349 Clinical Trial.

4

Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study.

Chapman PB, Morrissey DM, Panageas KS, Hamilton WB, Zhan C, Destro AN, Williams L, Israel RJ, Livingston PO. Chapman PB, et al. Clin Cancer Res. 2000 Mar;6(3):874-9. Clin Cancer Res. 2000. PMID: 10741710 Clinical Trial.

5

Vaccination with a bivalent G(M2) and G(D2) ganglioside conjugate vaccine: a trial comparing doses of G(D2)-keyhole limpet hemocyanin.

Chapman PB, Morrisey D, Panageas KS, Williams L, Lewis JJ, Israel RJ, Hamilton WB, Livingston PO. Chapman PB, et al. Clin Cancer Res. 2000 Dec;6(12):4658-62. Clin Cancer Res. 2000. PMID: 11156217 Clinical Trial.

6

Temozolomide plus thalidomide in patients with advanced melanoma: results of a dose-finding trial.

Hwu WJ, Krown SE, Panageas KS, Menell JH, Chapman PB, Livingston PO, Williams LJ, Quinn CJ, Houghton AN. Hwu WJ, et al. Among authors: chapman pb. J Clin Oncol. 2002 Jun 1;20(11):2610-5. doi: 10.1200/JCO.2002.09.034. J Clin Oncol. 2002. PMID: 12039921 Clinical Trial.

7

Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma.

Hwu WJ, Krown SE, Menell JH, Panageas KS, Merrell J, Lamb LA, Williams LJ, Quinn CJ, Foster T, Chapman PB, Livingston PO, Wolchok JD, Houghton AN. Hwu WJ, et al. Among authors: chapman pb. J Clin Oncol. 2003 Sep 1;21(17):3351-6. doi: 10.1200/JCO.2003.02.061. J Clin Oncol. 2003. PMID: 12947072 Clinical Trial.

8

Variates of survival in metastatic uveal melanoma.

Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB. Rietschel P, et al. Among authors: chapman pb. J Clin Oncol. 2005 Nov 1;23(31):8076-80. doi: 10.1200/JCO.2005.02.6534. J Clin Oncol. 2005. PMID: 16258106

9

Adjuvant therapy of melanoma.

Shah GD, Chapman PB. Shah GD, et al. Among authors: chapman pb. Cancer J. 2007 May-Jun;13(3):217-22. doi: 10.1097/PPO.0b013e318074dfd4. Cancer J. 2007. PMID: 17620773 Review.

10

Melanoma vaccines.

Chapman PB. Chapman PB. Semin Oncol. 2007 Dec;34(6):516-23. doi: 10.1053/j.seminoncol.2007.09.013. Semin Oncol. 2007. PMID: 18083375 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page